Working Groups

Our three research programs have organized the following working groups aligned with program-specific aims. The research program leaders work closely with the working group leaders to provide support for basic scientists and clinical investigators. The objective of these groups is to provide a platform for investigators to interact, disseminate ideas, create new collaborations and strengthen ongoing interactions, with the goal of increasing submissions of multi-P grant applications. The working groups include research program members as well as postdoctoral fellows, graduate students and research faculty from across UF.

Cancer AI Working Group

The mission of the Cancer AI Working Group is to develop collaborative research, expertise and network capacity in artificial intelligence (AI) at the UF Health Cancer Center.

DNA Repair Working Group

The mission of the DNA Repair Working Group is to conduct cross-disciplinary cutting-edge research in DNA replication, damage and repair to advance the understanding of the mechanisms of oncogenesis.

DNA Rapir

Immuno-Oncology Working Group

The mission of the UF Health Cancer Center Immuno-Oncology Working Group is to strengthen the interactions between Cancer Center investigators who work in tumor immunology and immuno-oncology.

Microbiome Working Group

The UF Health Cancer Center has developed a Microbiome Working Group that discusses exciting news within the microbiome — new breakthroughs or high impact publications — while fostering collaborations.

Myeloid Working Group

The mission of the UF Health Cancer Center Myeloid Working Group is to catalyze myeloid neoplasia research through hypothesis-driven, collaborative and translational clinical trials.

Targeted Therapeutics Working Group

The mission of the UF Health Cancer Center Targeted Therapeutics Working Groups is to facilitate development of targeted therapeutic approaches to improve treatments of cancer.

Targeted Therapeutics

Tobacco Control Working Group

The UF Health Cancer Center Tobacco Control Working Group brings together public health, translational and clinical researchers with the common goal of investigating ways to reduce and ultimately eliminate tobacco-related morbidity and mortality.